Repligen Working Capital vs Total Debt Analysis
RGEN Stock | USD 166.39 5.14 3.00% |
Trend analysis of Repligen balance sheet accounts such as Total Stockholder Equity of 2.1 B, Property Plant And Equipment Net of 339.1 M, Retained Earnings of 460.8 M or Cash of 788.9 M provides information on Repligen's total assets, liabilities, and equity, which is the actual value of Repligen to its prevalent stockholders. By breaking down trends over time using Repligen balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Repligen |
About Repligen Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Repligen at a specified time, usually calculated after every quarter, six months, or one year. Repligen Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Repligen and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Repligen currently owns. An asset can also be divided into two categories, current and non-current.
Repligen Balance Sheet Chart
Repligen Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how Repligen uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, Repligen's Retained Earnings are very stable compared to the past year. As of the 15th of April 2024, Cash is likely to grow to about 788.9 M, while Net Debt is likely to drop (41.5 M). Add Fundamental
Total Current Liabilities
Total Current Liabilities is an item on Repligen balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Repligen are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most indicators from Repligen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Repligen current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.At this time, Repligen's Selling General Administrative is very stable compared to the past year. As of the 15th of April 2024, Enterprise Value Over EBITDA is likely to grow to 79.75, while Tax Provision is likely to drop about 7.4 M.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 391.3M | 455.7M | 284.2M | 538.9M | Total Revenue | 670.5M | 801.5M | 638.8M | 768.0M |
Repligen fundamental ratios Correlations
Click cells to compare fundamentals
Repligen Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Repligen fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 1.4B | 1.9B | 2.4B | 2.5B | 2.8B | 3.0B | |
Short Long Term Debt Total | 263.3M | 275.4M | 366.1M | 423.0M | 711.8M | 747.4M | |
Other Current Liab | 28.3M | 37.8M | 60.7M | 65.8M | 53.2M | 55.9M | |
Total Current Liabilities | 48.3M | 319.0M | 375.3M | 404.2M | 158.2M | 166.1M | |
Total Stockholder Equity | 5.8M | 65.8M | 1.8B | 397.3M | 2.0B | 2.1B | |
Property Plant And Equipment Net | 74.2M | 92.0M | 226.5M | 315.7M | 323.0M | 339.1M | |
Net Debt | (265.1M) | (441.9M) | (237.8M) | (100.5M) | (39.5M) | (41.5M) | |
Retained Earnings | 5.8M | 65.8M | 194.1M | 397.3M | 438.8M | 460.8M | |
Cash | 528.4M | 717.3M | 603.8M | 523.5M | 751.3M | 788.9M | |
Non Current Assets Total | 758.3M | 1.0B | 1.4B | 1.5B | 1.7B | 1.8B | |
Non Currrent Assets Other | 238K | 573K | 615K | 815K | 1.3M | 1.3M | |
Cash And Short Term Investments | 528.4M | 717.3M | 603.8M | 623.8M | 751.3M | 788.9M | |
Net Receivables | 43.7M | 71.4M | 117.4M | 116.2M | 124.2M | 130.4M | |
Common Stock Shares Outstanding | 49.2M | 53.9M | 57.3M | 57.5M | 56.4M | 29.9M | |
Liabilities And Stockholders Equity | 346.2M | 439.5M | 2.4B | 1.0B | 2.8B | 3.0B | |
Non Current Liabilities Total | 292.0M | 54.8M | 233.0M | 209.8M | 695.0M | 729.8M | |
Inventory | 54.8M | 95.0M | 184.5M | 238.3M | 202.3M | 212.4M | |
Other Current Assets | 3.1M | 14.1M | 19.3M | 17.4M | 33.2M | 34.9M | |
Other Stockholder Equity | 14.5M | (2.6M) | 1.6B | 33.8M | 1.6B | 1.6B | |
Total Liab | 340.3M | 373.7M | 608.3M | 614.0M | 853.2M | 895.9M | |
Property Plant And Equipment Gross | 74.2M | 92.0M | 297.2M | 408.0M | 451.7M | 474.3M | |
Total Current Assets | 641.8M | 902.4M | 931.7M | 998.1M | 1.1B | 1.2B | |
Accumulated Other Comprehensive Income | (15.0M) | 2.1M | (16.9M) | (34.4M) | (37.4M) | (35.6M) | |
Accounts Payable | 11.4M | 16.9M | 36.2M | 27.6M | 19.6M | 20.5M | |
Short Term Debt | 3.6M | 249.0M | 263.6M | 291.6M | 75.1M | 101.1M | |
Other Assets | 3.2M | 28.2M | 2.5M | 1.7M | 1.5M | 1.6M | |
Common Stock Total Equity | 521K | 548K | 553K | 556K | 639.4K | 389.2K | |
Common Stock | 521K | 548K | 553K | 556K | 558K | 398.5K | |
Property Plant Equipment | 48.5M | 66.9M | 125.0M | 190.7M | 219.3M | 230.2M | |
Other Liab | 32.3M | 28.4M | 130.5M | 78.4M | 90.1M | 94.6M | |
Current Deferred Revenue | 5.0M | 15.3M | 14.8M | 19.3M | 10.3M | 5.4M | |
Good Will | 468.4M | 618.3M | 860.4M | 855.5M | 987.1M | 1.0B | |
Intangible Assets | 212.6M | 287.1M | 337.3M | 353.7M | 400.5M | 420.5M | |
Net Tangible Assets | 378.8M | 623.7M | 552.4M | 701.5M | 806.7M | 847.1M | |
Retained Earnings Total Equity | 5.8M | 65.8M | 194.1M | 397.3M | 456.9M | 479.7M | |
Capital Surpluse | 1.1B | 1.5B | 1.6B | 1.5B | 1.8B | 1.9B |
Currently Active Assets on Macroaxis
LTC | Litecoin | |
STETH | Staked Ether | |
LINK | Chainlink | |
XLM | Stellar | |
CRO | Cronos |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Repligen. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. To learn how to invest in Repligen Stock, please use our How to Invest in Repligen guide.Note that the Repligen information on this page should be used as a complementary analysis to other Repligen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..
Complementary Tools for Repligen Stock analysis
When running Repligen's price analysis, check to measure Repligen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Repligen is operating at the current time. Most of Repligen's value examination focuses on studying past and present price action to predict the probability of Repligen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Repligen's price. Additionally, you may evaluate how the addition of Repligen to your portfolios can decrease your overall portfolio volatility.
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
CEOs Directory Screen CEOs from public companies around the world |
Is Repligen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repligen. If investors know Repligen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repligen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.55) | Earnings Share 0.74 | Revenue Per Share 11.464 | Quarterly Revenue Growth (0.17) | Return On Assets 0.0131 |
The market value of Repligen is measured differently than its book value, which is the value of Repligen that is recorded on the company's balance sheet. Investors also form their own opinion of Repligen's value that differs from its market value or its book value, called intrinsic value, which is Repligen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repligen's market value can be influenced by many factors that don't directly affect Repligen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repligen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repligen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repligen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.